港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

拨康视云-B

4.330

-0.130-2.91%

成交量：23.40万

成交额：101.80万

市值：36.59亿

市盈率：-2.67

高：4.450

开：4.450

低：4.300

收：4.460

52周最高：9.740

52周最低：3.940

股本：8.45亿

香港流通股本：8.45亿

量比：0.97

换手率：0.03%

股息：- -

股息率：- -

每股收益(LYR):-1.621

净资产收益率：--

总资产收益率：-44.38%

市净率：-1.43

市盈率(LYR):-2.67

市销率: 45.96

数据加载中...

总览公司新闻资讯公告

拨康视云-B08月06日主力净流入22.4万元散户资金抛售

【IPO前哨】再次递表！旺山旺水生物估值超44亿，这些点值得关注

拨康视云-B07月30日主力净流出74.6万元散户资金买入

拨康视云-B07月28日主力净流出256.5万元散户资金买入

港股IPO上半年表现亮眼，融资额荣登全球第一！下半年IPO机会抢先看

老虎资讯综合

拨康视云-B07月22日获主力加仓50.4万元

拨康视云-B07月18日遭主力抛售22.8万元

港股医疗IPO热度不减，11家募资超181亿，39家排队，百利天恒“闯关”倒计时

拨康视云-B07月14日遭主力抛售14.1万元

拨康视云-B07月10日主力净流出66.7万元散户资金买入

“IPO盛宴”强势回归

艾美达医药咨询

近期国内融资|泰德医药、拨康视云港交所上市

6家创新药新锐公司完成新一轮融资！有3家来自中国

四战IPO，这家眼科新贵成功上市

拨康视云-B07月04日主力净流出237.9万元散户资金买入

异动解读 | 拨康视云-B盘中大跌6.45%，上市后持续下跌，较发行价已跌超42%

异动解读 | 拨康视云-B盘中大跌6.45%，上市次日较招股价已跌超42%

70后实控人接盘前妻公司冲击IPO，二婚娶90后

正大天晴重组人凝血因子VIIa获批上市；拨康视云上市首日破发

手握2款3期新药，眼科明星Biotech港股上市

动脉新医药

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02592/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"拨康视云-B","latestPrice":4.33,"timestamp":1763366895008,"preClose":4.46,"halted":0,"volume":234000,"delay":0,"floatShares":844999999,"shares":844999999,"eps":-1.6209587773916962,"marketStatus":"未开盘","change":-0.13,"latestTime":"11-17 16:08:15","open":4.45,"high":4.45,"low":4.3,"amount":1017990,"amplitude":0.033632,"askPrice":4.4,"askSize":1000,"bidPrice":4.33,"bidSize":13500,"shortable":3,"etf":0,"ttmEps":-1.3093289180134169,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":4.46,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":0.965347,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":844999999,"roa":"-44.38%","roe":"--","lyrEps":-1.620959,"volumeRatio":0.965347,"shares":844999999,"dividePrice":0,"high":4.45,"amplitude":0.033632,"preClose":4.46,"low":4.3,"week52Low":3.94,"pbRate":"-1.43","psRate":"45.96","week52High":9.74,"institutionHeld":0,"latestPrice":4.33,"committee":0.862069,"eps":-1.6209587773916962,"divideRate":0,"volume":234000,"delay":0,"ttmEps":-1.3093289180134169,"open":4.45,"prevYearClose":10.1,"prevWeekClose":4.46,"prevMonthClose":4.71,"prevQuarterClose":4.51,"fiveDayClose":4.7,"twentyDayClose":4.78,"sixtyDayClose":5.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2025-11-14","current":-3.307012,"percent":0.365591,"low":-13.478827,"twenty":-12.207573,"median":-6.465107,"eighty":-5.621104,"high":-5.348116,"avg":-8.53714,"sd":3.119566,"marketCap":3741462218},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586},{"date":"2025-08-29","current":-5.503941,"twenty":-6.295753,"median":-5.870846,"eighty":-5.538055,"marketCap":4253186871},{"date":"2025-09-05","current":-5.413205,"twenty":-6.239682,"median":-5.742284,"eighty":-5.49926,"marketCap":4186075441},{"date":"2025-09-12","current":-12.640894,"twenty":-6.350655,"median":-5.870846,"eighty":-5.508123,"marketCap":4118964011},{"date":"2025-09-19","current":-12.711577,"twenty":-6.612702,"median":-6.004685,"eighty":-5.525012,"marketCap":4135741868},{"date":"2025-09-26","current":-11.804503,"twenty":-12.358821,"median":-6.058573,"eighty":-5.527436,"marketCap":3842129362},{"date":"2025-10-03","current":-6.439136,"twenty":-12.191113,"median":-6.134046,"eighty":-5.53457,"marketCap":2096453591},{"date":"2025-10-10","current":-5.988337,"twenty":-11.881825,"median":-6.134089,"eighty":-5.548508,"marketCap":1949083838},{"date":"2025-10-17","current":-12.3346,"twenty":-12.21981,"median":-6.187936,"eighty":-5.561014,"marketCap":4009907937},{"date":"2025-10-24","current":-11.844495,"twenty":-12.25273,"median":-6.279578,"eighty":-5.580054,"marketCap":3850518291},{"date":"2025-10-31","current":-12.15705,"twenty":-12.335851,"median":-6.333467,"eighty":-5.585568,"marketCap":3951185436},{"date":"2025-11-07","current":-11.838569,"twenty":-12.273198,"median":-6.424535,"eighty":-5.601607,"marketCap":3850518291},{"date":"2025-11-14","current":-11.510378,"twenty":-12.207573,"median":-6.465107,"eighty":-5.621104,"marketCap":3741462218}],"updateTime":1763377323318},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02592\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557683374","title":"拨康视云-B08月06日主力净流入22.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2557683374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557683374?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 16:15","pubTimestamp":1754468126,"startTime":"0","endTime":"0","summary":"08月06日, 拨康视云-B股价涨2.96%，报收5.22元，成交金额169.3万元，换手率0.04%，振幅3.94%，量比0.42。拨康视云-B今日主力资金净流入22.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.28%，主力资金累计净流入22.4万元；近20日主力资金累计净流出389.3万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170107a478594f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170107a478594f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2557421303","title":"【IPO前哨】再次递表！旺山旺水生物估值超44亿，这些点值得关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2557421303","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557421303?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 10:16","pubTimestamp":1754446586,"startTime":"0","endTime":"0","summary":"2025年以来，维立志博-B（09887.HK）、拨康视云-B（02592.HK）、映恩生物-B（09606.HK）、脑动极光-B（06681.HK）在内的多家生物科技企业已经通过第18A章登陆港股市场。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202508_1/2c18d3df-96d9-4ded-a96b-b96d580c488a.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202508_1/2c18d3df-96d9-4ded-a96b-b96d580c488a.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6892bafa5a77128902028478","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1189","01877","09606","BK1583","BK1161","02592","06681","BK1515"],"gpt_icon":1},{"id":"2555041083","title":"拨康视云-B07月30日主力净流出74.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2555041083","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555041083?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 16:15","pubTimestamp":1753863320,"startTime":"0","endTime":"0","summary":"07月30日, 拨康视云-B股价跌0.54%，报收5.57元，成交金额523.1万元，换手率0.11%，振幅3.57%，量比1.46。拨康视云-B今日主力资金净流出74.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.96%，主力资金累计净流出331.2万元；近20日主力资金累计净流出644.7万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730165144a6c96148&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730165144a6c96148&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02592"],"gpt_icon":0},{"id":"2554715447","title":"拨康视云-B07月28日主力净流出256.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554715447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554715447?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 16:15","pubTimestamp":1753690550,"startTime":"0","endTime":"0","summary":"07月28日, 拨康视云-B股价跌1.24%，报收5.57元，成交金额653.7万元，换手率0.14%，振幅3.37%，量比1.63。拨康视云-B今日主力资金净流出256.5万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.28%，主力资金累计净流出245.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出570.1万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165757a6c5a3e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165757a6c5a3e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"1117162350","title":"港股IPO上半年表现亮眼，融资额荣登全球第一！下半年IPO机会抢先看","url":"https://stock-news.laohu8.com/highlight/detail?id=1117162350","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117162350?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 11:36","pubTimestamp":1753241761,"startTime":"0","endTime":"0","summary":"2025上半年港股市场势头向好，港股IPO上半年表现尤为亮眼，42宗首次公开招股发行，合共集资额逾过1,070亿港元，与去年同期相比，上市数量增长40%，融资总额飙升逾7倍。整体来看，2025年上半年港股市场凭借政策红利、资金回流与情绪修复实现强势复苏，医药、消费、A+H板块成为IPO主力；展望下半年，在巨头排队、政策持续利好的背景下，港股市场热度有望进一步延续。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"港股IPO上半年表现亮眼，融资额荣登全球第一！下半年IPO机会抢先看","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","02648","02508","01304","09678","06603","02643","02617","02573","02651","01828","02590","03288","02050","02592","06168","02609","06883","09881","02619","02605","02597","06613"],"gpt_icon":0},{"id":"2553327122","title":"拨康视云-B07月22日获主力加仓50.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553327122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553327122?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 16:15","pubTimestamp":1753172108,"startTime":"0","endTime":"0","summary":"07月22日，拨康视云-B股价收平报5.69元，成交金额321.4万元，换手率0.07%，振幅1.76%，量比0.39。拨康视云-B今日主力资金净流入50.4万元，上一交易日主力净流入40.9万元。该股近5个交易日下跌7.63%，主力资金累计净流入8.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出274.0万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722165328a45bdf9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722165328a45bdf9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","BK1161"],"gpt_icon":0},{"id":"2552494706","title":"拨康视云-B07月18日遭主力抛售22.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552494706","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552494706?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 16:15","pubTimestamp":1752826541,"startTime":"0","endTime":"0","summary":"07月18日, 拨康视云-B股价跌2.16%，报收5.89元，成交金额557.3万元，换手率0.11%，振幅4.49%，量比0.61。拨康视云-B今日主力资金净流出22.8万元，上一交易日主力净流出75.0万元。该股近5个交易日上涨2.97%，主力资金累计净流出65.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出365.4万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718171916a4531ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718171916a4531ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592"],"gpt_icon":0},{"id":"2551116742","title":"港股医疗IPO热度不减，11家募资超181亿，39家排队，百利天恒“闯关”倒计时","url":"https://stock-news.laohu8.com/highlight/detail?id=2551116742","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551116742?lang=zh_cn&edition=fundamental","pubTime":"2025-07-15 08:25","pubTimestamp":1752539117,"startTime":"0","endTime":"0","summary":"据LiveReport大数据，截至2025年7月14日，港股今年共计50家IPO，其中医疗保健行业合计11家，占比22%，今年的医疗保健行业的IPO数量接近去年全年的12家。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202507_1/5bb97970-aeb9-4394-8077-488ef8d961bc.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202507_1/5bb97970-aeb9-4394-8077-488ef8d961bc.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/68759fed2308298517b7f12d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02592","01276","02617","BK1191","BK1161"],"gpt_icon":1},{"id":"2551909628","title":"拨康视云-B07月14日遭主力抛售14.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551909628","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551909628?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 16:15","pubTimestamp":1752480936,"startTime":"0","endTime":"0","summary":"07月14日, 拨康视云-B股价跌3.15%，报收5.54元，成交金额888.4万元，换手率0.19%，振幅4.37%，量比1.03。拨康视云-B今日主力资金净流出14.1万元，连续3日净流出，上一交易日主力净流出0.3万元。该股近5个交易日下跌5.30%，主力资金累计净流出76.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出314.1万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714170115a449798c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714170115a449798c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592"],"gpt_icon":0},{"id":"2550261737","title":"拨康视云-B07月10日主力净流出66.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550261737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550261737?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 16:15","pubTimestamp":1752135340,"startTime":"0","endTime":"0","summary":"07月10日, 拨康视云-B股价跌1.53%，报收5.80元，成交金额659.3万元，换手率0.14%，振幅3.06%，量比0.10。拨康视云-B今日主力资金净流出66.7万元，上一交易日主力净流入24.9万元。该股近5个交易日下跌6.45%，主力资金累计净流出299.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出299.8万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165629a4422ff2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165629a4422ff2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592"],"gpt_icon":1},{"id":"2550683564","title":"“IPO盛宴”强势回归","url":"https://stock-news.laohu8.com/highlight/detail?id=2550683564","media":"艾美达医药咨询","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550683564?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 15:00","pubTimestamp":1752044427,"startTime":"0","endTime":"0","summary":"2025年7月1日，上交所官网显示，武汉禾元生物科技股份有限公司科创板IPO成功通过上交所上市审核委员会审议，成为科创板第五套上市标准重启后首家过会的IPO企业。2025年的A股生物医药IPO市场呈现出积极且结构化的新格局。亦诺微医药、微脉、百力司康等数十家医健企业已向港交所递交上市申请，排队等候上市，场面火爆，预示着下半年IPO热潮将持续。此外，多个IPO项目获得投资者热烈追捧。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709150735a69ec54e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709150735a69ec54e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600276","01877","LU1997244956.HKD","LU2495084118.USD","BK0028","LU2488822045.USD","LU1064131003.USD","159982","01801","02617","BK0188","LU1328615791.USD","LU0405327148.USD","BK0196","LU0405327494.USD","LU1997245094.SGD","LU1997245177.USD","LU1969619763.USD","BK0239","LU2328871848.SGD","02561","BK0060","LU1655091616.SGD","BK0183","BK0012","LU1064130708.USD","02592","LU2148510915.USD"],"gpt_icon":0},{"id":"2549539224","title":"近期国内融资|泰德医药、拨康视云港交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2549539224","media":"药菓","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549539224?lang=zh_cn&edition=fundamental","pubTime":"2025-07-07 18:01","pubTimestamp":1751882490,"startTime":"0","endTime":"0","summary":"公司致力于开发新一代治疗性和诊断用抗体药物，通过自主研发的智能抗体技术，能够高效设计并生成满足临床需求的抗体，同时显著降低治疗性抗体的开发成本。禾元生物成立于2006年，以植物表达动物蛋白的方式，生产药品、药用辅料及科研试剂。这也是重启科创板第五套上市标准后，首家按此标准成功过会的IPO企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191409a43bbb36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707191409a43bbb36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03880","02592"],"gpt_icon":1},{"id":"2549058684","title":"6家创新药新锐公司完成新一轮融资！有3家来自中国","url":"https://stock-news.laohu8.com/highlight/detail?id=2549058684","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549058684?lang=zh_cn&edition=fundamental","pubTime":"2025-07-07 15:30","pubTimestamp":1751873423,"startTime":"0","endTime":"0","summary":"根据数据统计，6月30日~7月6日，全球范围内有至少6家致力于创新药研发的新锐公司宣布完成新一轮融资，包括麦科奥特、拨康视云等。业内表示，这些创新药研发新锐公司的融资进展，不仅为各自的研发项目和商业化进程提供了有力的资金支持，也将推动全球创新药研发行业的进一步发展，为各类疾病的治疗带来新的希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707153403953941d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707153403953941d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1574","02592","BK1161"],"gpt_icon":1},{"id":"2549316281","title":"四战IPO，这家眼科新贵成功上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2549316281","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549316281?lang=zh_cn&edition=fundamental","pubTime":"2025-07-05 07:31","pubTimestamp":1751671895,"startTime":"0","endTime":"0","summary":"在此之前，拨康视云曾四次向港交所递交上市申请，最终成功上市。经营层面面临的挑战，尤其是持续的财务亏损及收入匮乏，成为其上市之路历经波折的关键因素之一。而与参天制药的战略合作，则被视作推动其成功上市的重要催化剂。目前，全球尚未有专门用于治疗翼状胬肉的药物。小结整体来看，拨康视云的短期价值主要建立在CBT-001的成功之上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250705073519a72f8a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250705073519a72f8a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592"],"gpt_icon":1},{"id":"2548615973","title":"拨康视云-B07月04日主力净流出237.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2548615973","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548615973?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 16:15","pubTimestamp":1751616909,"startTime":"0","endTime":"0","summary":"07月04日, 拨康视云-B股价跌5.48%，报收5.86元，成交金额4443.2万元，换手率0.86%，振幅14.84%，量比0.00。该股近5个交易日下跌41.98%，主力资金累计净流出237.9万元；近20日主力资金累计净流出237.9万元，其中净流出天数为1日。|07月04日主力加仓幅度排名||#|股票简称|主力净额占比|#|环球战略集团股权|8.77%|#|高地股份|3.66%|#|吉宏股份|2.34%|#|...|...|#2538|拨康视云-B|-0.05%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165307a72e7758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704165307a72e7758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592"],"gpt_icon":0},{"id":"1111120890","title":"异动解读 | 拨康视云-B盘中大跌6.45%，上市后持续下跌，较发行价已跌超42%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111120890","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111120890?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 15:02","pubTimestamp":1751612554,"startTime":"0","endTime":"0","summary":"港股市场上，拨康视云-B今日盘中大跌6.45%，延续了上市以来的跌势。截至盘中，该股报5.81港元，成交额达3729.14万港元。值得注意的是，这已是该股上市后的第二个交易日，而其股价较招股价已累计下跌超过42%，引发市场关注。其中，公司拥有两款核心产品CBT-001和CBT-009，均为自主开发。尽管拨康视云-B在眼科药物研发领域展现出潜力，但其上市后的持续下跌反映出投资者对该股的谨慎态度。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"417db6c0ab0fdec18dfd33a47098c1b2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02592"],"gpt_icon":1},{"id":"1109428087","title":"异动解读 | 拨康视云-B盘中大跌6.45%，上市次日较招股价已跌超42%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109428087","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109428087?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 15:02","pubTimestamp":1751612543,"startTime":"0","endTime":"0","summary":"拨康视云-B今日盘中大跌6.45%，延续上市首日的跌势。截至下午2点55分，该股报5.81港元，成交额达3729.14万港元。值得注意的是，与招股价相比，拨康视云-B的股价已累计下跌超过42%，引发市场关注。根据公司招股书显示，拨康视云-B拥有两款核心产品CBT-001和CBT-009。其中，CBT-001用于治疗翼状胬肉，公司已分别于2022年6月和2023年9月在美国和中国启动第3期多地区临床试验。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"417db6c0ab0fdec18dfd33a47098c1b2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02592"],"gpt_icon":1},{"id":"2548388797","title":"70后实控人接盘前妻公司冲击IPO，二婚娶90后","url":"https://stock-news.laohu8.com/highlight/detail?id=2548388797","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548388797?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 20:01","pubTimestamp":1751544060,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　近日，武汉里得电力科技股份有限公司 北交所IPO申请获受理，保荐机构为开源证券股份有限公司。　　本次IPO前，王颂锋担任公司董事长兼总经理，合计控制公司64%的表决权股份，是公司的控股股东和实际控制人。其开盘平开，总市值80亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2025-07-03/doc-infefhcf3766512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SPD","02592"],"gpt_icon":1},{"id":"2548389651","title":"正大天晴重组人凝血因子VIIa获批上市；拨康视云上市首日破发","url":"https://stock-news.laohu8.com/highlight/detail?id=2548389651","media":"氨基观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548389651?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 19:09","pubTimestamp":1751540990,"startTime":"0","endTime":"0","summary":"正大天晴又有新收获。7月3日，创新药企拨康视云港股上市。二级市场方面，公司表现不佳，上市首日破发，大跌38.61%。9）正大天晴重组人凝血因子VIIa获批上市7月3日，据NMPA官网，正大天晴的注射用重组人凝血因子VIIa已获批上市，适应症为抑制物阳性先天性血友病A或B患者以及某些特定类型罕见出血性疾病患者群体出血的治疗和外科手术或有创操作出血的防治。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703191301a72ca04f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703191301a72ca04f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592"],"gpt_icon":1},{"id":"2548896683","title":"手握2款3期新药，眼科明星Biotech港股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2548896683","media":"动脉新医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548896683?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 19:05","pubTimestamp":1751540741,"startTime":"0","endTime":"0","summary":"7月3日，“眼科创新药新锐”Cloudbreak Pharma Inc.拨康视云在港交所正式上市。其全球治疗药物市场规模预计将于2027年达到2.73亿美元、2032年达到25.29亿美元，复合年增长率为56.0%。因此，CBT-001有望成为治疗翼状胬肉的全球首创药物，享有先发优势。弗若斯特沙利文报告显示，全球治疗青少年近视药物的市场规模由2018年的7230万美元增加至2022年的8400万美元，复合年增长率为3.8%。2022年，全球睑板腺功能异常相关的干眼症患者人数将达到9.232亿人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703190942a4cd3dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703190942a4cd3dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","07226","HSTECH","HSCEI"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":81,"code":"91000000","status":"200"}]}}